Mycronic AB
Mycronic AB (publ) develops, manufactures, and sells production equipment for electronics industry in Sweden, rest of Europe, the United States, other Americas, China, South Korea, rest of Asia, and internationally. It operates through four segments: Pattern Generators, High Flex, High Volume, and Global Technologies. The Pattern Generators segment develops, manufactures, and markets mask writers… Read more
Mycronic AB (0MQG) - Net Assets
Latest net assets as of September 2021: Skr3.72 Billion SEK
Based on the latest financial reports, Mycronic AB (0MQG) has net assets worth Skr3.72 Billion SEK as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr6.12 Billion) and total liabilities (Skr2.40 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr3.72 Billion |
| % of Total Assets | 60.79% |
| Annual Growth Rate | 24.25% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 7.27 |
Mycronic AB - Net Assets Trend (2016–2020)
This chart illustrates how Mycronic AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Mycronic AB (2016–2020)
The table below shows the annual net assets of Mycronic AB from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | Skr3.36 Billion | +13.19% |
| 2019-12-31 | Skr2.97 Billion | +25.08% |
| 2018-12-31 | Skr2.38 Billion | +33.47% |
| 2017-12-31 | Skr1.78 Billion | +26.11% |
| 2016-12-31 | Skr1.41 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Mycronic AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 196169200000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr1.94 Billion | 57.61% |
| Common Stock | Skr98.00 Million | 2.91% |
| Other Components | Skr1.33 Billion | 39.48% |
| Total Equity | Skr3.36 Billion | 100.00% |
Mycronic AB Competitors by Market Cap
The table below lists competitors of Mycronic AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Energean plc
PINK:EERGF
|
$1.63 Billion |
|
Shenzhen Topband Co Ltd
SHE:002139
|
$1.63 Billion |
|
Fluence Energy Inc
NASDAQ:FLNC
|
$1.63 Billion |
|
Daewoo Engineering & Construction
KO:047040
|
$1.63 Billion |
|
Shenyang Xingqi Pharmaceutical Co Ltd
SHE:300573
|
$1.63 Billion |
|
Sinbon Electronics Co Ltd
TW:3023
|
$1.63 Billion |
|
Zhewen Interactive Group Co Ltd
SHG:600986
|
$1.63 Billion |
|
Bestway Marine & Energy Technology Co Ltd
SHE:300008
|
$1.63 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Mycronic AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 2,972,000,000 to 3,364,000,000, a change of 392,000,000 (13.2%).
- Net income of 693,000,000 contributed positively to equity growth.
- Dividend payments of 196,000,000 reduced retained earnings.
- Other factors decreased equity by 105,000,000.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr693.00 Million | +20.6% |
| Dividends Paid | Skr196.00 Million | -5.83% |
| Other Changes | Skr-105.00 Million | -3.12% |
| Total Change | Skr- | 13.19% |
Book Value vs Market Value Analysis
This analysis compares Mycronic AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Mycronic AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.60%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 17.85%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 1.58x
- Recent ROE (20.60%) is below the historical average (30.98%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 37.28% | 22.69% | 0.84x | 1.95x | Skr385.14 Million |
| 2017 | 35.04% | 20.79% | 0.92x | 1.82x | Skr445.74 Million |
| 2018 | 33.23% | 20.88% | 0.90x | 1.77x | Skr551.93 Million |
| 2019 | 28.77% | 19.85% | 0.90x | 1.62x | Skr557.80 Million |
| 2020 | 20.60% | 17.85% | 0.73x | 1.58x | Skr356.60 Million |
Industry Comparison
This section compares Mycronic AB's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Mycronic AB (0MQG) | Skr3.72 Billion | 37.28% | 0.65x | $1.63 Billion |
| Nyfosa AB (0A0K) | $3.48 Billion | 34.90% | 2.92x | $966.63 Million |
| Tethys Oil AB (0A1V) | $56.23 Million | 21.07% | 0.01x | $122.95 Million |
| High Templar Tech Limited (0A2T) | $11.29 Billion | 0.81% | 0.10x | $258.25 Million |
| Strategy Inc (0A7O) | $361.50 Million | 1.39% | 0.55x | $38.08 Billion |
| NACON SASU (0A9N) | $210.72 Million | 8.63% | 0.51x | $7.82 Million |
| Antin Infrastructure Partners (0AA5) | $32.26 Million | 152.50% | 1.23x | $545.92 Million |
| Truecaller AB Series B (0AA7) | $1.51 Billion | 34.81% | 0.30x | $277.14 Million |
| Brockhaus Technologies AG (0AAW) | $315.34 Million | 15.55% | 1.46x | $74.17 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $-10.19 Million | 0.00% | 0.00x | $71.96 Million |
| Kalray S.A. (0ABT) | $39.07 Million | -59.55% | 1.26x | $33.84 Million |